Logo

Cogenics Installs 454 FLX in European Lab; Roche to Help It Market Services

Mar 29, 2007
NEW YORK (GenomeWeb News) — Clinical Data today said it has installed a 454 Life Sciences GS FLX genome sequencer in one of its Cogenics labs in Europe, and has signed a co-marketing agreement with Roche Diagnostics to support its sequencing plans.
 
Cogenics said Roche, which sold it the sequencer, will help it market sequencing and genome-wide expression profiling services to clients worldwide. 
 
Robert Bondaryk, Cogenics’ senior vice president and general manager, said the company expects the agreement to contribute increased sales and revenues by consolidating its position as a genomics and pharmacogenomics services provider.
 
Financial terms of the agreement were not released.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.